Bristol-Myers Squibb readies to tackle pivotal resistance - Analysis - 04-11-2022

Bristol-Myers Squibb Company's stock (BMY) rallied in the intraday levels, amid the dominance of the main upward medium-term trend, while impacted by exiting an ascending correctional price channel recently, buoyed by trading above the 50-day SMA.

Therefore we expect more gains for the stock, targeting the pivotal resistance of 80.60, provided it settles above 75.70. 

Expected trend for today: Bullish